Progenics And Wyeth Announce FDA Has Approved Relistor Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced that the U.S. Food and Drug Administration (FDA) has approved RELISTOR? (methylnaltrexone bromide) subcutaneous injection for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient.
Source: www.medicalnewstoday.comWomen's Biological Clock Revealed: Hormone May Predict Age At Menopause Age at menopause may now be predicted more realistically according to a new study accepted for publication in the Journal of Clinical Endocrinology & Metabolism (JCEM). The study revealed that anti Mullerian hormone (AMH) levels are related to the onset of menopause and are able to specify a woman's reproductive age more accurately than chronological age alone.The levels of AMH in the blood reflect the number of small follicles present in a woman's ovaries.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 4:00 AM
